Global New
Born Screening Market, by Product (Instruments, and Assay Kits and Reagents),
by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, and
Others), by Application (Phenylketonuria (PKU), Maple Syrup Urine Disease
Critical Congenital Cardiac Disease, Hearing Disability, Sickle Cell Disease,
and Others), by End User (Hospitals, Maternity and Specialty Clinics, and
Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,412.2 Mn
in 2021 and is expected to exhibit a CAGR of 10.5% during the forecast period
(2021-2028), as highlighted in a new report published by Coherent Market
Insights.
Increasing government support for
new born screening and development in screening technology are expected to
drive the market growth during the forecast period. For instance, New born
Foundation in USA, a global non-profit organization is working in collaboration
with public health and government agencies, healthcare providers and
researchers, international NGOs working in the new born health ecosystem. Under
New born Foundation, 3.2 million infants have been screened for heart defects
and other health conditions. For instance, in 2013, New born Foundation
launched BORN project, which impacted 31 provinces and around 400,000 new born,
as well as 50 maternal and child health facilities in China.
Global New Born Screening Market–
Impact of Coronavirus (COVID-19) Pandemic
The coronavirus or COVID-19
outbreak that started from Wuhan, China has spread across continents, affecting
various industries globally. Supply of raw materials has been severely
disrupted due to the forced quarantine, and lack of labour and raw materials.
As the link between regional warehouses is not smooth, the transportation of
raw materials between regions cannot be carried out successfully.
This shortage of raw materials
and components have affected the supply chain of the global new born screening
market. Supply chain and manufacturing activities in India, Italy, Spain, U.K.,
and the U.S. have been disrupted due to lockdowns implemented by governments in
the past few months, while countries such as Saudi Arabia, UAE, Egypt, and
others are facing problems with regards to transportation of instruments and kits
used for new born screening.
Furthermore, the global new born screening
market players are facing major challenges due to the COVID-19 pandemic on
various fronts. The major challenges include supply of raw materials required
for manufacturing instruments and reagent kits due to irregularities in
transportation facility.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2192
Browse Market Data 43 Tables and
40 Figures spread through 288 Pages and in-depth TOC on “Global New Born
Screening Market”- Forecast to 2028,
Global New Born Screening Market, by Product (Instruments, and Assay Kits and
Reagents), by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine
Test, and Others), by Application (Phenylketonuria, Critical Congenital Cardiac
Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease,
and Others), by End User (Hospitals, Maternity and Specialty Clinics, and
Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa)
Moreover, high birth rate and increasing
rate of neonatal diseases are expected to drive the market growth during the
forecast period. Newborn population is one of the most vulnerable group
population for various disease such as epilepsy, polio encephaliphitis, asthma,
chronic obstructive pulmonary disease (COPD), and other respiratory disease,
leukemia, diarrhea, anemia, and other rare disease that results in substantial
economic burden. Hence, it is important to conduct new born screening for early
detection of the diseases.
Key Takeaways of the Global New
Born Screening Market:
The global new born screening
market is expected to grow with a CAGR of 10.5% during the forecast period due
to key players operating in the market are adopting strategies such as
collaborations and acquisitions in order to expand their product portfolio. For
instance, in November 2020, Natus Medical Inc., a medical device company
acquired Babybe GmbH, a company that develops its patented remote mother to
baby communication technology and soft robotics for neonatal healthcare. The
company’s technology will add to Natus Medical Inc.’s Newborn Care portfolio of
products.
Among product, instruments
segment accounted for the highest CAGR in global new born screening market
during forecast period. For instance, in July 2017, Department of Biotechnology
(DBT), Ministry of Science and Technology, (Government of India) launched Sohum
– the newborn hearing screening device developed by SIB startup, Sohum
Innovation Labs India Pvt. Ltd., in India.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192
On the basis of test type, dry
blood spot test accounted for the largest market share in the global new born
screening market over the forecast period. For instance, in January 2019,
Virginia Department of Health, announced the launch of Virginia New born
Screening Program. The program include education about new born screening and
conducting dried-blood spot screening tests, referral, follow-up and diagnosis,
dietary and medical management, and treatment in Hospitals of Virginia.
On the basis of application,
phenylketonuria (PKU) segment is expected to grow with the fastest growth rate
in global new born screening market during forecast period. For instance, in
2017, Scientific Center of Obstetrics, Gynecology and Perinatology, Republican
Medical Genetic Consultation, Almaty, Kazakhstan collaboratively initiated mass
screening of Phenylketonuria (PKU) from year 2017 to 2019. They screened around
1 million newborns for Phenylketonuria (PKU) globally.
Among the end user, hospitals
segment accounted for the largest share in global new born screening market in
2020. For instance, in May 2021, Cure Sanfilippo Foundation, a non –government
organization (NGO) announced the initiation of the program called pilot new
born screening for multiple disorders, which includes Sanfilippo syndrome type
A and type B. This program is supported by eight New York hospitals such as the
Maimonides Medical Center, in Brooklyn; New York-Presbyterian/Columbia
University Medical Center, in Manhattan; Mount Sinai Hospital and Mount Sinai
West, and the North Shore University Hospital, and others.
Among the regions, Asia Pacific
region accounted for the largest CAGR in global new born screening market in
2021. Increasing programmes by key players for newborn screening expected to
drive growth of the Asia Pacific newborn screening market during the forecast
period.
Major players operating in global
new born screening market include Agilent Technologies, Inc, Bio-rad
laboratories, Inc. Medtronic Plc, Masimo Corporation, Natus Medical Inc.,
Perkin Elmer, Inc., ZenTec S.A., Trivitron Healthcare Pvt Ltd, Waters
Technologies Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co.
Ltd, Chromesystem Instruments and Chemicals GmbH, and RECIPE Chemicals+
Instrument GmbH.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2192
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment